Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Shepstone

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Trials|May 31, 2020
Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
Trials|January 23, 2020
Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
BMJ Open|July 2, 2021
DECRYPT trial: study protocol for a phase II randomised controlled trial of cognitive therapy for post-traumatic stress disorder (PTSD) in youth exposed to multiple traumatic stressorsLeila Allen, Polly-Anna Ashford, Ella Beeson, et al.
BMJ Open|November 18, 2022
Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocolLeanne Greene, Aidin Aryankhesal, Molly Megson, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Trials|December 6, 2017
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trialSimon P Hammond, Jane L Cross, Lee Shepstone, et al.
The New England Journal of Medicine|October 5, 2023
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 DiabetesTara T M Lee, Corinne Collett, Simon Bergford, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Trials|May 31, 2020
Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
Trials|January 23, 2020
Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS studyChristine M Bond, Richard Holland, David P Alldred, et al.
BMJ Open|July 2, 2021
DECRYPT trial: study protocol for a phase II randomised controlled trial of cognitive therapy for post-traumatic stress disorder (PTSD) in youth exposed to multiple traumatic stressorsLeila Allen, Polly-Anna Ashford, Ella Beeson, et al.
BMJ Open|November 18, 2022
Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocolLeanne Greene, Aidin Aryankhesal, Molly Megson, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Trials|December 6, 2017
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trialSimon P Hammond, Jane L Cross, Lee Shepstone, et al.
The New England Journal of Medicine|October 5, 2023
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 DiabetesTara T M Lee, Corinne Collett, Simon Bergford, et al.
Pageof 14